ArticleNeuropsychiatric disease and treatment2013

Double-blind, placebo-controlled, two-period, crossover trial to examine the pharmacokinetics of lisdexamfetamine dimesylate in healthy older adults.

James Ermer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.